Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

An Open-label, Phase 2 Study of ACP-196 in Subjects With Waldenström Macroglobulinemia

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT02180724
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:28:10.194090+00:00
Published At
2020-04-24T00:00:00+00:00
Record Updated At
2026-03-20
Results Posted At
2020-04-24
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Waldenstr\u00f6m Macroglobulinemia (WM)"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-03-20"
protocolSection.identificationModule.nctId
"NCT02180724"
protocolSection.identificationModule.officialTitle
"An Open-label, Phase 2 Study of ACP-196 in Subjects With Waldenstr\u00f6m Macroglobulinemia"
protocolSection.statusModule.overallStatus
"ACTIVE_NOT_RECRUITING"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2020-04-24"

Study condition terms

  • Waldenström Macroglobulinemia (WM) (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.